• Consensus Rating: Hold
  • Consensus Price Target: $121.88
  • Forecasted Upside: 38.46 %
  • Number of Analysts: 10
  • Breakdown:
  • 4 Sell Ratings
  • 1 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$88.02
▼ -2.09 (-2.32%)

This chart shows the closing price for ARKAY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Arkema Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ARKAY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ARKAY

Analyst Price Target is $121.88
▲ +38.46% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Arkema in the last 3 months. The average price target is $121.88, with a high forecast of $146.00 and a low forecast of $87.00. The average price target represents a 38.46% upside from the last price of $88.02.

This chart shows the closing price for ARKAY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 10 investment analysts is to hold stock in Arkema. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 4 sell ratings
2/25/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 4 sell ratings
5/26/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 4 sell ratings
8/24/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 4 sell ratings
11/22/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 4 sell ratings
2/20/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 4 sell ratings
5/21/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 4 sell ratings
7/20/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 4 sell ratings
8/19/2022

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 4 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/20/2022Credit Suisse GroupLower TargetUnderperform ➝ Underperform€103.00 ➝ €87.00
7/18/2022Morgan StanleyLower TargetUnderweight ➝ Underweight€105.00 ➝ €91.00
7/14/2022BarclaysBoost Target€129.00 ➝ €131.00
7/14/2022UBS GroupDowngradeNeutral ➝ Sell
7/12/2022JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
7/6/2022Stifel NicolausLower TargetBuy ➝ Buy€139.00 ➝ €123.00
7/5/2022Deutsche Bank AktiengesellschaftLower Target€145.00 ➝ €135.00
4/8/2022Credit Suisse GroupBoost Target€101.00 ➝ €103.00
3/30/2022Kepler Capital MarketsDowngradeBuy ➝ Hold
2/25/2022The Goldman Sachs GroupBoost Target€145.00 ➝ €146.00
2/25/2022JPMorgan Chase & Co.Boost Target€136.00 ➝ €142.00
2/4/2022BarclaysBoost Target€124.00 ➝ €129.00
1/21/2022JPMorgan Chase & Co.Boost Target€134.00 ➝ €136.00
12/13/2021Morgan StanleyDowngradeEqual Weight ➝ Underweight
12/8/2021UBS GroupLower TargetNeutral ➝ Neutral€123.00 ➝ €120.00
12/7/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
11/11/2021JPMorgan Chase & Co.Reiterated RatingOverweight
11/11/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
10/14/2021Morgan StanleyReiterated RatingEqual Weight
10/14/2021Jefferies Financial GroupInitiated CoverageBuy
10/13/2021UBS GroupReiterated RatingNeutral
9/7/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
9/3/2021CitigroupInitiated CoverageBuy
9/3/2021HSBCUpgradeHold ➝ Buy
8/19/2021Morgan StanleyReiterated RatingEqual Weight
8/13/2021JPMorgan Chase & Co.Reiterated RatingOverweight
7/30/2021Credit Suisse GroupReiterated RatingUnderperform
7/14/2021UBS GroupReiterated RatingNeutral
7/12/2021Credit Suisse GroupSet TargetUnderperform$126.72
7/7/2021BarclaysReiterated RatingEqual Weight
7/2/2021JPMorgan Chase & Co.Reiterated RatingOverweight
6/10/2021Redburn PartnersUpgradeSell ➝ Neutral
5/18/2021BarclaysReiterated RatingEqual Weight
5/12/2021Credit Suisse GroupReiterated RatingUnderperform
5/11/2021Berenberg BankReiterated RatingHold
5/7/2021JPMorgan Chase & Co.Reiterated RatingOverweight
5/7/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
4/30/2021BarclaysReiterated RatingEqual Weight
4/14/2021UBS GroupReiterated RatingNeutral
4/12/2021JPMorgan Chase & Co.Reiterated RatingOverweight
3/9/2021Stifel NicolausUpgradeHold ➝ Buy
3/3/2021Berenberg BankReiterated RatingHold
3/1/2021Kepler Capital MarketsUpgradeHold ➝ Buy
2/2/2021Redburn PartnersDowngradeBuy ➝ Sell
1/26/2021Credit Suisse GroupDowngradeOutperform ➝ Underperform
12/18/2020Societe GeneraleReiterated RatingHold
12/8/2020UBS GroupReiterated RatingNeutral
12/7/2020BarclaysReiterated RatingEqual Weight
12/7/2020Morgan StanleyDowngradeOverweight ➝ Equal Weight
11/6/2020Credit Suisse GroupReiterated RatingOutperform
10/6/2020Morgan StanleyReiterated RatingOverweight
10/5/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
9/22/2020CitigroupReiterated RatingBuy
8/14/2020HSBCDowngradeBuy ➝ Hold
8/4/2020JPMorgan Chase & Co.Reiterated RatingOverweight
8/3/2020UBS GroupReiterated RatingNeutral
7/13/2020Morgan StanleyReiterated RatingOverweight
7/8/2020UBS GroupReiterated RatingNeutral
6/19/2020Credit Suisse GroupReiterated RatingOutperform
6/1/2020UBS GroupReiterated RatingNeutral
3/30/2020Morgan StanleyReiterated RatingOverweight
3/24/2020JPMorgan Chase & Co.Reiterated RatingOverweight
3/4/2020The Goldman Sachs GroupUpgradeSell ➝ Buy
2/25/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
2/4/2020Kepler Capital MarketsUpgradeReduce ➝ Hold
1/16/2020BarclaysDowngradeOverweight ➝ Equal Weight
4/3/2019Berenberg BankInitiated CoverageHold
1/17/2019Credit Suisse GroupUpgradeNeutral ➝ Outperform
11/29/2018MacquarieInitiated CoverageOutperform ➝ Outperform
11/19/2018The Goldman Sachs GroupDowngradeNeutral ➝ Sell
11/7/2018Credit Suisse GroupUpgradeHold
11/13/2017Credit Suisse GroupDowngradeNeutral ➝ Underperform
(Data available from 8/19/2017 forward)

News Sentiment Rating

0.67 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/21/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/20/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/22/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/21/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/21/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/20/2022
  • 2 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
7/20/2022
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/19/2022

Current Sentiment

  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Arkema logo
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. The company operates through Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermediates segments. It provides adhesive solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets. The company also offers advanced materials consisting of specialty polyamides and polyvinylidene fluoride; and performance additives, such as specialty surfactants and molecular sieves, organic peroxides, thiochemicals, and hydrogen peroxide for use in automotive and transportation, oil and gas, renewable energies, consumer goods, electronics, construction, coatings, animal nutrition, and water treatment sectors. In addition, it provides coating solutions comprising EU/US acrylics and coating resins; sartomer photocure resins and coatex rheology additives; decorative paints, industrial coatings, and adhesives; and solutions for applications in the paper, superabsorbents, water treatment and oil and gas extraction, and 3D printing and electronics industries. Further, the company offers fluorogases and acrylics; and industrial intermediate chemicals used in construction, refrigeration and air conditioning, automotive, coatings, and water treatment sectors. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France.
Read More

Today's Range

Now: $88.02
Low: $87.15
High: $88.64

50 Day Range

MA: $92.65
Low: $84.61
High: $104.88

52 Week Range

Now: $88.02
Low: $82.23
High: $152.18

Volume

6,330 shs

Average Volume

10,075 shs

Market Capitalization

$6.54 billion

P/E Ratio

5.48

Dividend Yield

3.00%

Beta

1.41

Frequently Asked Questions

What sell-side analysts currently cover shares of Arkema?

The following Wall Street sell-side analysts have issued reports on Arkema in the last twelve months: Barclays PLC, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, HSBC Holdings plc, Jefferies Financial Group Inc., JPMorgan Chase & Co., Kepler Capital Markets, Morgan Stanley, Stifel Nicolaus, The Goldman Sachs Group, Inc., and UBS Group AG.
View the latest analyst ratings for ARKAY.

What is the current price target for Arkema?

8 Wall Street analysts have set twelve-month price targets for Arkema in the last year. Their average twelve-month price target is $121.88, suggesting a possible upside of 38.5%. The Goldman Sachs Group, Inc. has the highest price target set, predicting ARKAY will reach $146.00 in the next twelve months. Credit Suisse Group AG has the lowest price target set, forecasting a price of $87.00 for Arkema in the next year.
View the latest price targets for ARKAY.

What is the current consensus analyst rating for Arkema?

Arkema currently has 4 sell ratings, 1 hold rating and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ARKAY, but not buy more shares or sell existing shares.
View the latest ratings for ARKAY.

What other companies compete with Arkema?

How do I contact Arkema's investor relations team?

Arkema's physical mailing address is 420 rue d`Estienne d Orves, Colombes Cedex I0, 92700. The basic materials company's listed phone number is (314) 900-8080 and its investor relations email address is [email protected] The official website for Arkema is www.arkema.com. Learn More about contacing Arkema investor relations.